patent on semaglutide Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants Semaglutide patent expiry in India

doi:10.1207/S15327914NC4501_12 5

BOOK NOW Increasing energy and stamina Improving sleep and recovery Enhancing focus and mental clarity Supporting fat loss and muscle gain Improving sexual function and desire Reducing inflammation and accelerating healing Supporting longevity and overall vitality How soon will I notice the results

*Correspondence: Richard G

The FDA also reported receiving 520 adverse event reports related to compounded semaglutide and 480 reports concerning compounded tirzepatide as of late spring of the prior year

Semaglutide alone is projected to grow from $64.42 billion in 2025 to $170.75 billion by 2033 (CAGR ~13%)